Diet-induced obese mice exhibit altered heterologous immunity during a secondary 2009 pandemic H1N1 infection

Journal of Immunology

Volumn 191, Issue 5, 2013, Pages 2474-2485

  Milner, J Justin ^a   Sheridan, Patricia A ^a   Karlsson, Erik A ^b   Schultz Cherry, Stacey ^b   Shi, Qing ^a   Beck, Melinda A ^a  

^a University of North Carolina   (United States)

^b ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2009 H1N1 INFLUENZA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; CD8+ T LYMPHOCYTE; CELL ISOLATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DISEASE ASSOCIATION; DISEASE SEVERITY; LUNG INJURY; LYMPHOCYTE COUNT; LYMPHOCYTE FUNCTION; MALE; MEMORY T LYMPHOCYTE; MOUSE; NONHUMAN; OBESITY; PANDEMIC INFLUENZA; PNEUMONIA; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; VIRUS TITRATION;

ANIMALS; ANTIBODIES, VIRAL; CROSS REACTIONS; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; INFLUENZA A VIRUS, H1N1 SUBTYPE; MALE; MICE; MICE, INBRED C57BL; MICE, OBESE; OBESITY; ORTHOMYXOVIRIDAE INFECTIONS; PANDEMICS;

EID: 84883318210     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1202429     Document Type: Article

References (71)

1. Otte, A., M. Sauter, L. Alleva, S. Baumgarte, K. Klingel, and G. Gabriel. 2011. Differential host determinants contribute to the pathogenesis of 2009 pandemic H1N1 and human H5N1 influenza A viruses in experimental mouse models. Am. J. Pathol. 179: 230-239.
2. Itoh, Y., K. Shinya, M. Kiso, T. Watanabe, Y. Sakoda, M. Hatta, Y. Muramoto, D. Tamura, Y. Sakai-Tagawa, T. Noda, et al. 2009. In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses. Nature 460: 1021-1025.
3. Maines, T. R., A. Jayaraman, J. A. Belser, D. A. Wadford, C. Pappas, H. Zeng, K. M. Gustin, M. B. Pearce, K. Viswanathan, Z. H. Shriver, et al. 2009. Transmission and pathogenesis of swine-origin 2009 A(H1N1) influenza viruses in ferrets and mice. Science 325: 484-487.
4. Munster, V. J., E. de Wit, J. M. A. van den Brand, S. Herfst, E. J. A. Schrauwen, T. M. Bestebroer, D. van de Vijver, C. A. Boucher, M. Koopmans, G. F. Rimmelzwaan, et al. 2009. Pathogenesis and transmission of swine-origin 2009 A(H1N1) influenza virus in ferrets. Science 325: 481-483.
5. Presanis, A. M., D. De Angelis, A. Hagy, C. Reed, S. Riley, B. S. Cooper, L. Finelli, P. Biedrzycki, and M. Lipsitch; New York City Swine Flu Investigation Team. 2009. The severity of pandemic H1N1 influenza in the United States, from April to July 2009: a Bayesian analysis. PLoS Med. 6: e1000207.
6. Kelly, H. A. 2010. A pandemic response to a disease of predominantly seasonal intensity. Med. J. Aust. 192: 81-83.
7. Anonymous; Centers for Disease Control and Prevention (CDC). 2009. Update: novel influenza A (H1N1) virus infection - Mexico, March-May, 2009. MMWR Morb. Mortal. Wkly. Rep. 58: 585-589.
8. Girard, M. P., J. S. Tam, O. M. Assossou, and M. P. Kieny. 2010. The 2009 A (H1N1) influenza virus pandemic: a review. Vaccine 28: 4895-4902.
9. Bautista, E., T. Chotpitayasunondh, Z. Gao, S. A. Harper, M. Shaw, T. M. Uyeki, S. R. Zaki, F. G. Hayden, D. S. Hui, J. D. Kettner, et al; Writing Committee of the WHO Consultation on Clinical Aspects of Pandemic (H1N1) 2009 Influenza. 2010. Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection. N. Engl. J. Med. 362: 1708-1719.
10. Hancock, K., V. Veguilla, X. Lu, W. Zhong, E. N. Butler, H. Sun, F. Liu, L. Dong, J. R. DeVos, P. M. Gargiullo, et al. 2009. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N. Engl. J. Med. 361: 1945-1952.
11. Ikonen, N., M. Strengell, L. Kinnunen, P. Osterlund, J. Pirhonen, M. Broman, I. Davidkin, T. Ziegler, and I. Julkunen. 2010. High frequency of cross-reacting antibodies against 2009 pandemic influenza A(H1N1) virus among the elderly in Finland. Euro Surveill. 15: 19478.
12. Anonymous; Centers for Disease Control and Prevention (CDC). 2009. Serum cross-reactive antibody response to a novel influenza A (H1N1) virus after vaccination with seasonal influenza vaccine. MMWR Morb. Mortal. Wkly. Rep. 58: 521-524.
13. Lee, V. J., J. K. Tay, M. I. C. Chen, M. C. Phoon, M. L. Xie, Y. Wu, C. X. X. Lee, J. Yap, K. R. Sakharkar, M. K. Sakharkar, et al. 2010. Inactivated trivalent seasonal influenza vaccine induces limited cross-reactive neutralizing antibody responses against 2009 pandemic and 1934 PR8 H1N1 strains. Vaccine 28: 6852-6857.
14. Iorio, A., B. Camilloni, E. Lepri, M. Neri, M. Basileo, and A. Azzi. 2011. Induction of cross-reactive antibodies to 2009 pandemic H1N1 influenza virus (pH1N1) after seasonal vaccination (Winters 2003/04 and 2007/08). Procedia Vaccinol. 4: 50-58.
15. Iorio, A. M., O. Bistoni, M. Galdiero, E. Lepri, B. Camilloni, A. M. Russano, M. Neri, M. Basileo, and F. Spinozzi. 2012. Influenza viruses and crossreactivity in healthy adults: humoral and cellular immunity induced by seasonal 2007/2008 influenza vaccination against vaccine antigens and 2009 A (H1N1) pandemic influenza virus. Vaccine 30: 1617-1623.
16. Valkenburg, S. A., J. A. Rutigliano, A. H. Ellebedy, P. C. Doherty, P. G. Thomas, and K. Kedzierska. 2011. Immunity to seasonal and pandemic influenza A viruses. Microbes Infect. 13: 489-501.
17. Thomas, P. G., R. Keating, D. J. Hulse-Post, and P. C. Doherty. 2006. Cellmediated protection in influenza infection. Emerg. Infect. Dis. 12: 48-54.
18. Ge, X., V. Tan, P. L. Bollyky, N. E. Standifer, E. A. James, and W. W. Kwok. 2010. Assessment of seasonal influenza A virus-specific CD4 T-cell responses to 2009 pandemic H1N1 swine-origin influenza A virus. J. Virol. 84: 3312-3319.
19. Tu, W., H. Mao, J. Zheng, Y. Liu, S. S. Chiu, G. Qin, P. L. Chan, K. T. Lam, J. Guan, L. Zhang, et al. 2010. Cytotoxic T lymphocytes established by seasonal human influenza cross-react against 2009 pandemic H1N1 influenza virus. J. Virol. 84: 6527-6535.
20. Subbramanian, R. A., S. Basha, M. T. Shata, R. C. Brady, and D. I. Bernstein. 2010. Pandemic and seasonal H1N1 influenza hemagglutinin-specific T cell responses elicited by seasonal influenza vaccination. Vaccine 28: 8258-8267.
21. Guo, H., F. Santiago, K. Lambert, T. Takimoto, and D. J. Topham. 2011. T cellmediated protection against lethal 2009 pandemic H1N1 influenza virus infection in a mouse model. J. Virol. 85: 448-455.
22. Greenbaum, J. A., M. F. Kotturi, Y. Kim, C. Oseroff, K. Vaughan, N. Salimi, R. Vita, J. Ponomarenko, R. H. Scheuermann, A. Sette, and B. Peters. 2009. Preexisting immunity against swine-origin H1N1 influenza viruses in the general human population. Proc. Natl. Acad. Sci. USA 106: 20365-20370.
23. Xing, Z., and C. J. Cardona. 2009. Preexisting immunity to pandemic (H1N1) 2009. Emerg. Infect. Dis. 15: 1847-1849.
24. Skountzou, I., D. G. Koutsonanos, J. H. Kim, R. Powers, L. Satyabhama, F. Masseoud, W. C. Weldon, Mdel. P. Martin, R. S. Mittler, R. Compans, and J. Jacob. 2010. Immunity to pre-1950 H1N1 influenza viruses confers crossprotection against the pandemic swine-origin 2009 A (H1N1) influenza virus. J. Immunol. 185: 1642-1649.
25. Alam, S., and A. J. Sant. 2011. Infection with seasonal influenza virus elicits CD4 T cells specific for genetically conserved epitopes that can be rapidly mobilized for protective immunity to pandemic H1N1 influenza virus. J. Virol. 85: 13310-13321.
26. Hillaire, M. L. B., S. E. van Trierum, J. H. C. M. Kreijtz, R. Bodewes, M. M. Geelhoed-Mieras, N. J. Nieuwkoop, R. A. M. Fouchier, T. Kuiken, A. D. M. E. Osterhaus, and G. F. Rimmelzwaan. 2011. Cross-protective immunity against influenza pH1N1 2009 viruses induced by seasonal A (H3N2) virus is mediated by virus-specific T-cells. J. Gen. Virol. 92: 2339-2349.
27. Sun, K., J. Ye, D. R. Perez, and D. W. Metzger. 2011. Seasonal FluMist vaccination induces cross-reactive T cell immunity against H1N1 (2009) influenza and secondary bacterial infections. J. Immunol. 186: 987-993.
28. Couch, R. B., R. L. Atmar, L. M. Franco, J. M. Quarles, D. Niño, J. M. Wells, N. Arden, S. Cheung, and J. W. Belmont. 2012. Prior infections with seasonal influenza A/H1N1 virus reduced the illness severity and epidemic intensity of pandemic H1N1 influenza in healthy adults. Clin. Infect. Dis. 54: 311-317.
29. LaMere, M. W., H. T. Lam, A. Moquin, L. Haynes, F. E. Lund, T. D. Randall, and D. A. Kaminski. 2011. Contributions of antinucleoprotein IgG to heterosubtypic immunity against influenza virus. J. Immunol. 186: 4331-4339.
30. Fang, Y., D. Banner, A. A. Kelvin, S. S. H. Huang, C. J. Paige, S. A. Corfe, K. P. Kane, R. C. Bleackley, T. Rowe, A. J. Leon, and D. J. Kelvin. 2012. Seasonal H1N1 influenza virus infection induces cross-protective pandemic H1N1 virus immunity through a CD8-independent, B cell-dependent mechanism. J. Virol. 86: 2229-2238.
31. Anonymous; Centers for Disease Control and Prevention (CDC). 2009. Intensive-care patients with severe novel influenza A (H1N1) virus infection - Michigan, June 2009. MMWR Morb. Mortal. Wkly. Rep. 58: 749-752.
32. Louie, J. K., M. Acosta, M. C. Samuel, R. Schechter, D. J. Vugia, K. Harriman, and B. T. Matyas; California Pandemic (H1N1) Working Group. 2011. A novel risk factor for a novel virus: obesity and 2009 pandemic influenza A (H1N1). Clin. Infect. Dis. 52: 301-312.
33. Morgan, O. W., A. Bramley, A. Fowlkes, D. S. Freedman, T. H. Taylor, P. Gargiullo, B. Belay, S. Jain, C. Cox, L. Kamimoto, et al. 2010. Morbid obesity as a risk factor for hospitalization and death due to 2009 pandemic influenza A (H1N1) disease. PLoS ONE 5: e9694.
34. Jain, S., L. Kamimoto, A. M. Bramley, A. M. Schmitz, S. R. Benoit, J. Louie, D. E. Sugerman, J. K. Druckenmiller, K. A. Ritger, R. Chugh, et al; 2009 Pandemic Influenza A (H1N1) Virus Hospitalizations Investigation Team. 2009. Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009. N. Engl. J. Med. 361: 1935-1944.
35. Van Kerkhove, M. D., K. A. H. Vandemaele, V. Shinde, G. Jaramillo-Gutierrez, A. Koukounari, C. A. Donnelly, L. O. Carlino, R. Owen, B. Paterson, L. Pelletier, et al; WHO Working Group for Risk Factors for Severe H1N1pdm Infection. 2011. Risk factors for severe outcomes following 2009 influenza A (H1N1) infection: a global pooled analysis. PLoS Med. 8: e1001053.
36. World Health Organization. May, 2012. WHO Factsheet 311: Obesity and Overweight. Available at: http://www.who.int/mediacentre/factsheets/fs311/en/ index.html. Accessed: July 15, 2013.
37. Milner, J. J., and M. A. Beck. 2012. The impact of obesity on the immune response to infection. Proc. Nutr. Soc. 71: 298-306.
38. Karlsson, E. A., P. A. Sheridan, and M. A. Beck. 2010. Diet-induced obesity impairs the T cell memory response to influenza virus infection. J. Immunol. 184: 3127-3133.
39. Sheridan, P., H. Paich, J. Handy, E. Karlsson, M. Hudgens, A. Sammon, L. Holland, S. Weir, T. Noah, and M. Beck. 2011. Obesity is associated with impaired immune response to influenza vaccination in humans. Int. J. Obes (Lond). 36: 1072-1077.
40. Kim, Y. H., J. K. Kim, D. J. Kim, J. H. Nam, S. M. Shim, Y. K. Choi, C. H. Lee, and H. Poo. 2012. Diet-induced obesity dramatically reduces the efficacy of a 2009 pandemic H1N1 vaccine in a mouse model. J. Infect. Dis. 205: 244-251.
41. Gianazza, E., C. Sensi, I. Eberini, F. Gilardi, M. Giudici, and M. Crestani. 2012. Inflammatory serum proteome pattern in mice fed a high-fat diet. Amino Acids 44: 1001-1008.
42. Smith, A. G., P. A. Sheridan, J. B. Harp, and M. A. Beck. 2007. Diet-induced obese mice have increased mortality and altered immune responses when infected with influenza virus. J. Nutr. 137: 1236-1243.
43. Reed, L. J., and H. Muench. 1938. A simple method of estimating fifty per cent endpoints. Am. J. Epidemiol. 27: 493-497.
44. Wortham, B. W., B. L. Eppert, G. T. Motz, J. L. Flury, M. Orozco-Levi, K. Hoebe, R. J. Panos, M. Maxfield, S. W. Glasser, A. P. Senft, et al. 2012. NKG2D mediates NK cell hyperresponsiveness and influenza-induced pathologies in a mouse model of chronic obstructive pulmonary disease. J. Immunol. 188: 4468-4475.
45. Glasser, S. W., T. L. Witt, A. P. Senft, J. E. Baatz, D. Folger, M. D. Maxfield, H. T. Akinbi, D. A. Newton, D. R. Prows, and T. R. Korfhagen. 2009. Surfactant protein C-deficient mice are susceptible to respiratory syncytial virus infection. Am. J. Physiol. Lung Cell. Mol. Physiol. 297: L64-L72.
46. Snell, L. M., A. J. McPherson, G. H. Y. Lin, S. Sakaguchi, P. P. Pandolfi, C. Riccardi, and T. H. Watts. 2010. CD8 T cell-intrinsic GITR is required for T cell clonal expansion and mouse survival following severe influenza infection. J. Immunol. 185: 7223-7234.
47. Farag-Mahmod, F. I., P. R. Wyde, J. P. Rosborough, and H. R. Six. 1988. Immunogenicity and efficacy of orally administered inactivated influenza virus vaccine in mice. Vaccine 6: 262-268.
48. World Health Organization. 2010. Serological diagnosis of influenza by microneutralization assay. Available at: http://www.who.int/influenza/gisrs- laboratory/2010-12-06-serological-diagnosis-of-influenza-by-microneutralization- assay.pdf. Accessed: August 01, 2012.
49. De Rosa, V., C. Procaccini, G. Calì, G. Pirozzi, S. Fontana, S. Zappacosta, A. La Cava, and G. Matarese. 2007. A key role of leptin in the control of regulatory T cell proliferation. Immunity 26: 241-255.
50. Carragher, D. M., D. A. Kaminski, A. Moquin, L. Hartson, and T. D. Randall. 2008. A novel role for non-neutralizing antibodies against nucleoprotein in facilitating resistance to influenza virus. J. Immunol. 181: 4168-4176.
51. Lamere, M. W., A. Moquin, F. E. Lee, R. S. Misra, P. J. Blair, L. Haynes, T. D. Randall, F. E. Lund, and D. A. Kaminski. 2011. Regulation of antinucleoprotein IgG by systemic vaccination and its effect on influenza virus clearance. J. Virol. 85: 5027-5035.
52. Flynn, K. J., G. T. Belz, J. D. Altman, R. Ahmed, D. L. Woodland, and P. C. Doherty. 1998. Virus-specific CD8+ T cells in primary and secondary influenza pneumonia. Immunity 8: 683-691.
53. Effros, R. B., P. C. Doherty, W. Gerhard, and J. Bennink. 1977. Generation of both cross-reactive and virus-specific T-cell populations after immunization with serologically distinct influenza A viruses. J. Exp. Med. 145: 557-568.
54. Sallusto, F., D. Lenig, R. Förster, M. Lipp, and A. Lanzavecchia. 1999. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 401: 708-712.
55. Loebbermann, J., H. Thornton, L. Durant, T. Sparwasser, K. E. Webster, J. Sprent, F. J. Culley, C. Johansson, and P. J. Openshaw. 2012. Regulatory T cells expressing granzyme B play a critical role in controlling lung inflammation during acute viral infection. Mucosal Immunol. 5: 161-172.
56. Fulton, R. B., D. K. Meyerholz, and S. M. Varga. 2010. Foxp3+ CD4 regulatory T cells limit pulmonary immunopathology by modulating the CD8 T cell response during respiratory syncytial virus infection. J. Immunol. 185: 2382-2392.
57. Deiuliis, J., Z. Shah, N. Shah, B. Needleman, D. Mikami, V. Narula, K. Perry, J. Hazey, T. Kampfrath, M. Kollengode, et al. 2011. Visceral adipose inflammation in obesity is associated with critical alterations in tregulatory cell numbers. PLoS ONE 6: e16376.
58. Ma, X., J. Hua, A. R. Mohamood, A. R. A. Hamad, R. Ravi, and Z. Li. 2007. A high-fat diet and regulatory T cells influence susceptibility to endotoxin-induced liver injury. Hepatology 46: 1519-1529.
59. Betts, R. J., A. W. S. Ho, and D. M. Kemeny. 2011. Partial depletion of natural CD4+CD25+ regulatory T cells with anti-CD25 antibody does not alter the course of acute influenza A virus infection. PLoS ONE 6: e27849.
60. Betts, R. J., N. Prabhu, A. W. S. Ho, F. C. Lew, P. E. Hutchinson, O. Rotzschke, P. A. Macary, and D. M. Kemeny. 2012. Influenza A virus infection results in a robust, antigen-responsive, and widely disseminated Foxp3+ regulatory T cell response. J. Virol. 86: 2817-2825.
61. Sehrawat, S., and B. T. Rouse. 2011. Tregs and infections: on the potential value of modifying their function. J. Leukoc. Biol. 90: 1079-1087.
62. Wan, Y. Y., and R. A. Flavell. 2007. Regulatory T-cell functions are subverted and converted owing to attenuated Foxp3 expression. Nature 445: 766-770.
63. Josefowicz, S. Z., L. F. Lu, and A. Y. Rudensky. 2012. Regulatory T cells: mechanisms of differentiation and function. Annu. Rev. Immunol. 30: 531-564.
64. Karlsson, E. A., P. A. Sheridan, and M. A. Beck. 2010. Diet-induced obesity in mice reduces the maintenance of influenza-specific CD8+ memory T cells. J. Nutr. 140: 1691-1697.
65. Damjanovic, D., C. L. Small, M. Jeyanathan, S. McCormick, and Z. Xing. 2012. Immunopathology in influenza virus infection: uncoupling the friend from foe. Clin. Immunol. 144: 57-69.
66. Mauad, T., L. A. Hajjar, G. D. Callegari, L. F. F. da Silva, D. Schout, F. R. B. G. Galas, V. A. F. Alves, D. M. A. C. Malheiros, J. O. C. Auler, Jr., A. F. Ferreira, et al. 2010. Lung pathology in fatal novel human influenza A (H1N1) infection. Am. J. Respir. Crit. Care Med. 181: 72-79.
67. Lee, D. C. P., J. A. E. Harker, J. S. Tregoning, S. F. Atabani, C. Johansson, J. Schwarze, and P. J. M. Openshaw. 2010. CD25+ natural regulatory T cells are critical in limiting innate and adaptive immunity and resolving disease following respiratory syncytial virus infection. J. Virol. 84: 8790-8798.
68. Brincks, E. L., A. D. Roberts, T. Cookenham, S. Sell, J. E. Kohlmeier, M. A. Blackman, and D. L. Woodland. 2013. Antigen-specific memory regulatory CD4+Foxp3+ T cells control memory responses to influenza virus infection. J. Immunol. 190: 3438-3446.
69. O'Brien, K. B., P. Vogel, S. Duan, E. A. Govorkova, R. J. Webby, J. A. McCullers, and S. Schultz-Cherry. 2012. Impaired wound healing predisposes obese mice to severe influenza virus infection. J. Infect. Dis. 205: 252-261.
70. Easterbrook, J. D., R. L. Dunfee, L. M. Schwartzman, B. W. Jagger, A. Sandouk, J. C. Kash, M. J. Memoli, and J. K. Taubenberger. 2011. Obese mice have increased morbidity and mortality compared to non-obese mice during infection with the 2009 pandemic H1N1 influenza virus. Influenza Other Respi. Viruses 5: 418-425.
71. Zhang, A. J., K. K. To, C. Li, C. C. Lau, V. K. Poon, C. C. Chan, B. J. Zheng, I. F. Hung, K. S. Lam, A. Xu, and K. Y. Yuen. 2013. Leptin mediates the pathogenesis of severe 2009 pandemic influenza A(H1N1) infection associated with cytokine dysregulation in mice with diet-induced obesity. J. Infect. Dis. 207: 1270-1280.